GIA
VRTX icon

Gateway Investment Advisers’s Vertex Pharmaceuticals VRTX Stock Holding History

Gateway Investment Advisers’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$33.4M Buy
67,289
+168
+0.3% +$74.5K 0.33% 67
2026
Q1 		$30M Buy
67,121
+1,013
+2% +$472K 0.33% 69
2025
Q4 		$30M Buy
66,108
+182
+0.3% +$78.4K 0.28% 76
2025
Q3 		$25.8M Buy
65,926
+132
+0.2% +$55.2K 0.25% 81
2025
Q2 		$29.3M Sell
65,794
-59
-0.1% -$27.2K 0.32% 74
2025
Q1 		$31.9M Buy
65,853
+11
+0% +$5.13K 0.37% 69
2024
Q4 		$26.5M Sell
65,842
-719
-1% -$333K 0.3% 80
2024
Q3 		$31M Sell
66,561
-1,398
-2% -$672K 0.34% 73
2024
Q2 		$31.9M Sell
67,959
-1,543
-2% -$670K 0.36% 68
2024
Q1 		$29.1M Sell
69,502
-4,542
-6% -$1.92M 0.33% 83
2023
Q4 		$30.1M Buy
74,044
+2,176
+3% +$804K 0.35% 75
2023
Q3 		$25M Sell
71,868
-116
-0.2% -$40.6K 0.31% 82
2023
Q2 		$25.3M Buy
71,984
+6
+0% +$2.02K 0.3% 88
2023
Q1 		$22.7M Sell
71,978
-239
-0.3% -$71.7K 0.28% 99
2022
Q4 		$20.9M Sell
72,217
-4,207
-6% -$1.28M 0.26% 105
2022
Q3 		$22.1M Buy
76,424
+5,245
+7% +$1.51M 0.28% 95
2022
Q2 		$20.1M Sell
71,179
-16,074
-18% -$4.3M 0.23% 107
2022
Q1 		$22.8M Sell
87,253
-2,693
-3% -$639K 0.22% 107
2021
Q4 		$19.8M Sell
89,946
-12,423
-12% -$2.42M 0.19% 119
2021
Q3 		$18.6M Sell
102,369
-884
-0.9% -$173K 0.19% 114
2021
Q2 		$20.8M Sell
103,253
-12,869
-11% -$2.69M 0.21% 114
2021
Q1 		$25M Sell
116,122
-2,606
-2% -$572K 0.27% 93
2020
Q4 		$28.1M Sell
118,728
-687
-0.6% -$158K 0.31% 83
2020
Q3 		$32.5M Sell
119,415
-5,843
-5% -$1.61M 0.38% 71
2020
Q2 		$36.4M Sell
125,258
-14,930
-11% -$4.05M 0.43% 59
2020
Q1 		$33.4M Sell
140,188
-4,830
-3% -$1.11M 0.41% 63
2019
Q4 		$31.8M Buy
145,018
+3,279
+2% +$664K 0.31% 82
2019
Q3 		$24M Sell
141,739
-6,705
-5% -$1.19M 0.24% 106
2019
Q2 		$27.2M Sell
148,444
-246
-0.2% -$43K 0.25% 108
2019
Q1 		$27.4M Buy
148,690
+780
+0.5% +$144K 0.24% 105
2018
Q4 		$24.5M Buy
147,910
+15,796
+12% +$2.74M 0.23% 103
2018
Q3 		$25.5M Sell
132,114
-290
-0.2% -$51.6K 0.21% 116
2018
Q2 		$22.5M Sell
132,404
-2,501
-2% -$388K 0.2% 120
2018
Q1 		$22M Sell
134,905
-2,544
-2% -$416K 0.2% 128
2017
Q4 		$20.6M Sell
137,449
-91
-0.1% -$13.5K 0.18% 132
2017
Q3 		$20.9M Sell
137,540
-10,222
-7% -$1.54M 0.18% 132
2017
Q2 		$19M Sell
147,762
-32,418
-18% -$3.9M 0.17% 147
2017
Q1 		$19.7M Buy
180,180
+12,858
+8% +$1.13M 0.18% 146
2016
Q4 		$12.3M Sell
167,322
-8,682
-5% -$706K 0.12% 180
2016
Q3 		$15.3M Buy
176,004
+3,423
+2% +$323K 0.14% 171
2016
Q2 		$14.8M Buy
172,581
+10,684
+7% +$923K 0.13% 173
2016
Q1 		$12.9M Sell
161,897
-365
-0.2% -$33K 0.11% 184
2015
Q4 		$20.4M Buy
162,262
+538
+0.3% +$64.9K 0.17% 140
2015
Q3 		$16.8M Sell
161,724
-1,233
-0.8% -$158K 0.15% 162
2015
Q2 		$20.1M Sell
162,957
-7,617
-4% -$960K 0.17% 151
2015
Q1 		$20.1M Sell
170,574
-8
-0% -$959 0.17% 152
2014
Q4 		$20.3M Buy
170,582
+15,278
+10% +$1.72M 0.17% 149
2014
Q3 		$17.4M Buy
155,304
+10,005
+7% +$953K 0.14% 168
2014
Q2 		$13.8M Buy
145,299
+23,425
+19% +$1.64M 0.11% 196
2014
Q1 		$8.62M Buy
121,874
+38,570
+46% +$3.05M 0.07% 221
2013
Q4 		$6.19M Buy
83,304
+453
+0.5% +$31.5K 0.05% 248
2013
Q3 		$6.28M Buy
82,851
+23,560
+40% +$1.87M 0.05% 238
2013
Q2 		$4.74M Buy
+59,291
New +$4.37M 0.04% 260

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return
AAIS
ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return

Gateway Investment Advisers's VRTX Position: Q2 2026 in Review

Gateway Investment Advisers increased its Vertex Pharmaceuticals (VRTX) stake by 0.25% in Q2 2026, buying an estimated $74.5K and bringing the position to 67,289 shares worth $33.4M. The position accounts for 0.33% of the portfolio, ranked #67.

Gateway Investment Advisers first reported a position in VRTX in Q2 2013 and has held it in 53 quarters since. The position peaked at $36.4M in Q2 2020. 429 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Gateway Investment Advisers held 67,289 shares of Vertex Pharmaceuticals worth $33.4M as of Q2 2026.
  • Gateway Investment Advisers bought 168 Vertex Pharmaceuticals shares in Q2 2026, an estimated $74.5K.
  • Vertex Pharmaceuticals made up 0.33% of Gateway Investment Advisers's portfolio in Q2 2026, its #67 holding.
  • Gateway Investment Advisers first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
  • Gateway Investment Advisers's Vertex Pharmaceuticals position peaked at $36.4M in Q2 2020.
  • 429 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Gateway Investment Advisers's 13F filing for Q2 2026, filed 20 Jul 2026.